Treatment Approach for Moderate Depression

Understanding the Score

A PHQ-9 score of 12 indicates moderate depression requiring active intervention with consultation from psychology or psychiatry for diagnostic confirmation, combined with either pharmacologic treatment or structured psychological therapy, according to the Journal of Clinical Oncology 1, 2
The patient likely has several depressive symptoms that interfere with daily functioning but may not meet full criteria for major depressive disorder, with functional impairment ranging from mild to moderate 1

If the patient endorsed any frequency of self-harm thoughts, immediate referral for emergency psychiatric evaluation is mandatory regardless of the total score, as recommended by the Journal of Clinical Oncology 1, 2
Facilitate a safe environment and one-to-one observation if self-harm risk is present, as suggested by the Journal of Clinical Oncology 3

Determine associated sociodemographic factors, psychiatric or health comorbidities, and duration of depressive symptoms, as recommended by the Journal of Clinical Oncology 1
Assess the degree of functional impairment in work, relationships, and daily activities, according to the Journal of Clinical Oncology 1
Consider whether medical causes are contributing to symptoms, as suggested by the Journal of Clinical Oncology 3
Individually guided self-help based on cognitive behavioral therapy (CBT) with behavioral activation and problem-solving is a recommended psychological intervention option, according to Praxis Medical Insights 2
Structured physical activity programs are also a recommended psychological intervention option, as suggested by Praxis Medical Insights 2

Do not underestimate the severity of a score of 12—this represents clinically significant depression requiring active treatment, not just "watchful waiting", as warned by Praxis Medical Insights 2, 4
Do not fail to complete the full PHQ-9 if you've only administered the initial 2-item screen, as recommended by Praxis Medical Insights 2
Do not omit item 9 regarding self-harm, as this is critical for safety assessment, according to the Journal of Clinical Oncology and Praxis Medical Insights 1, 2
Use culturally sensitive assessments when possible, and tailor evaluation for patients with learning disabilities or cognitive impairments, as suggested by the Journal of Clinical Oncology and Praxis Medical Insights 1, 2